NEK2 and liver cancer: Building upon the identification of potent prognostic biomarkers in liver cancer (TPX2, TRIP13, and NEK2), we delved deeper into their regulatory networks using NetworkAnalyst, a powerful tool for exploring biological interactions depicted in Fig. 7.